ロード中...
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib
BACKGROUND: This study investigated whether the effectiveness of first-line tyrosine-kinase inhibitors was associated with sites of disease in patients with metastatic renal cell carcinoma (mRCC). METHODS: A retrospective cohort of consecutive mRCC patients receiving first-line sorafenib (SO) or sun...
保存先:
| 出版年: | Ther Adv Urol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4372524/ https://ncbi.nlm.nih.gov/pubmed/25829949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215571809 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|